Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. - Wikidata - awgldk - TriplyDB

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

http://www.wikidata.org/entity/Q37174245

about

Advanced techniques using contrast media in neuroimaging Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging Diagnosis and treatment in neuro-oncology: an oncological perspective The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives Emerging methods for disease monitoring in malignant gliomas Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel 1H-MRS Applied to Brain Tumor Analysis Brain Vascular Imaging Techniques Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.Perfusion MRI: the five most frequently asked clinical questions.Modeling of nanotherapeutics delivery based on tumor perfusion.Functional imaging in adult and paediatric brain tumours.Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.Differentiation of Low- and High-Grade Pediatric Brain Tumors with High b-Value Diffusion-weighted MR Imaging and a Fractional Order Calculus Model Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.Advanced MR Imaging in Neuro-oncology.Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma.Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.Principles, techniques, and applications of T2*-based MR imaging and its special applications.Advanced imaging techniques in brain tumors.Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model Functional MRI for radiotherapy of gliomas.Clinical impact of integrated physiologic brain tumor imaging.Prognostic value of blood flow measurements using arterial spin labeling in gliomas Perfusion CT imaging of brain tumors: an overview.Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma.Perfusion and permeability MR imaging of gliomas.Advances in MRI assessment of gliomas and response to anti-VEGF therapy.MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas.Neuroradiological viewpoint on the diagnostics of space-occupying brain lesions.Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas.Survival analysis of patients with high-grade gliomas based on data mining of imaging variables.

P2860

Q22252349-21B60D89-ADF8-4A7D-8DD8-50CC7FCAB452 Q26796223-3DC0ED3A-027D-41B6-8BDB-D96D5FB87A3E Q26860696-31CB9618-464A-43F8-B485-40927611A735 Q27021359-8001DBD5-87A0-4D6F-836B-661207295C17 Q27023823-833171B3-529A-4F6E-8BFF-1D0133FFF9B9 Q28547952-A0C89C83-09D5-4A30-BF1C-753009B455C3 Q30363574-42BB7A2F-9CD0-42A6-81CF-272F7F56A623 Q30414111-1B725A74-30F9-4C7E-9F8C-A2E00AB29F29 Q30416198-7EDC80E8-69F5-4313-8190-BFAF09E1734D Q30544603-9A4A4278-7244-463B-AB59-1B2386D008E3 Q30577397-D4FEE59D-8642-4E46-BDC7-B7743E9F775A Q30579847-438AE2E6-FEE7-4E16-8146-E980D25FAD63 Q30653828-3384EF4E-8A0D-4D94-833C-D874DBAD3E3B Q30692995-153BF8C3-763D-477E-BBC3-03A9E90C6B60 Q30930526-44A3598B-73B1-4632-BA49-013E8EE9031D Q30938805-764E2DFD-9AEF-4974-904B-CB9F18B4254C Q30963767-BACD58FA-89A9-4460-90CD-00FC429B0763 Q30967370-E9F20064-E576-4E36-BD4E-5963BEC43A9D Q30983681-2ED35C42-2833-4993-8754-287EBE3798BA Q30984368-9C0E6F81-FB99-4618-AB8A-4DFFA44817CE Q31137662-D80009E7-E8FA-44FC-8EFE-D8F0DBD90721 Q31153877-4A6292E0-9347-448D-B47D-5263233F0DB1 Q33503519-2F069218-9F14-43E6-B7E2-76CAF0D96DD6 Q33517391-3EDD8D2D-E176-4DE3-9175-6D79EA64AE81 Q33549622-EDB0042A-E638-4385-ABDF-124D8510A5FF Q33616603-9ED958DB-D660-4F1B-B77D-F8856E6C7F6B Q33631456-4A90767C-8A72-4049-BB43-FE62DD2AB41D Q33631461-8C48F4FF-168D-417A-8C21-4181F46DEAA5 Q33727772-CF4CADA8-2515-487E-A079-C67FACA36542 Q33738599-336A8E23-9274-41F4-BB4D-EE30C1931E61 Q33750912-ABAAAAB4-6253-4626-BC27-F15F70DCC063 Q33788231-48B121ED-0814-41DD-A631-1200A37419EE Q33793253-A66B89E5-186D-429B-9518-CA8FF490FA49 Q33812703-E02CBA65-9752-4615-BFFD-436502A2A7DD Q33888131-58BF05FB-C02B-449D-A9D9-93E5141B0701 Q33894461-8F725CBE-2FB4-47C6-AEE3-555999FE3FA0 Q34011150-7FF4565D-28FB-40AA-96BB-F0F912FACFEC Q34053148-6E8679A3-A8DE-4822-BF02-51BFBC20D7E0 Q34114203-4D12B2E0-FC1D-4749-A438-2C0DD1679F97 Q34155776-5794A9C6-38F1-486C-8728-955313F30527

P2860

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

http://www.wikidata.org/entity/Q37174245

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gliomas: predicting time to pr ...... enhanced perfusion MR imaging.

@en

Gliomas: predicting time to pr ...... enhanced perfusion MR imaging.

@nl

type

label

Gliomas: predicting time to pr ...... enhanced perfusion MR imaging.

@en

Gliomas: predicting time to pr ...... enhanced perfusion MR imaging.

@nl

prefLabel

Gliomas: predicting time to pr ...... enhanced perfusion MR imaging.

@en

Gliomas: predicting time to pr ...... enhanced perfusion MR imaging.

@nl

P1433

Q37174245-0F5326D1-B020-4334-B3DB-B41051291C2F

P1476

Q37174245-6A37C3EA-1B38-4AA7-B96F-F38BDF4CA046

P2093

Q37174245-13049EE4-DD56-4C95-809D-56DFD468C997

Q37174245-2F5F4DC7-0F43-497B-B002-6D0C6743DF14

Q37174245-64C26A78-F0E7-4020-B960-9732E69BD1DD

Q37174245-74488E2E-AE2C-437C-9F33-2714A88953B3

Q37174245-80F64817-2FE9-4DB0-9F2B-0C2FBD612E9C

Q37174245-A42F4417-3BCB-4B3A-9C2E-295F423C5A58

Q37174245-EA4E440B-3F66-468B-844B-331329F7F4F7

Q37174245-FFB97966-1276-443B-9127-A2A54E3B3168

P2860

Q37174245-1309A315-37D9-4B60-AD08-3D5B4B31326F

Q37174245-16E4FBF2-E941-48F9-9420-A28B5315A097

Q37174245-3D79829B-3641-47C5-AA6E-313A38735CB0

Q37174245-3F1EB77E-C047-4B21-934E-B41707888ED7

Q37174245-48116803-3B4A-458B-9689-7E94DD84D433

Q37174245-59844E0D-BC3D-4728-8E5B-5F6F60898105

Q37174245-79F3BB58-2FD4-4221-A030-6F0A5B6F0339

Q37174245-7DEAD8A1-2599-4AE6-83B2-2C21A7BF212E

Q37174245-7E42A2CD-1FF6-464E-ADD7-59D3143BDD25

Q37174245-86AC2556-860E-4EDC-BAA4-EE5F5399DB24

P304

Q37174245-951A8AB5-C9AC-4D5C-AE9B-C7A2DAE161D7

P31

Q37174245-09E912BA-2D3D-4111-AF95-4E9B974E539A

P356

Q37174245-CA41C5BA-DB32-4A62-BFD2-8C7FA2FF0E05

P407

Q37174245-A023488E-276D-41AB-B048-065007468D0D

P433

Q37174245-E13E7AC4-D629-4E10-8C68-C0EAF3AB9A80

P478

Q37174245-025B236B-ACBF-4254-A7F6-53406A7FAE59

P50

Q37174245-3A5B8409-0463-4BFA-9D80-549149806571

Q37174245-B45CD4CD-9A8F-480C-A642-187FE6445EDF

P577

Q37174245-210B339D-1869-43C9-BC3A-A676EE4A6D73

P698

Q37174245-BD9B5AEB-C0A4-4760-B57F-507FBAFACAFD

P932

Q37174245-6977349A-C03D-486A-8323-A33C8C8CC141

P356

RADIOL.2472070898

P1433

P1476

Gliomas: predicting time to pr ...... enhanced perfusion MR imaging.

@en

P2093

David Zagzag

http://www.w3.org/2001/XMLSchema#string

Douglas C Miller

http://www.w3.org/2001/XMLSchema#string

James S Babb

http://www.w3.org/2001/XMLSchema#string

John G Golfinos

http://www.w3.org/2001/XMLSchema#string

Meng Law

http://www.w3.org/2001/XMLSchema#string

Michael L Gruber

http://www.w3.org/2001/XMLSchema#string

Nicole Peccerelli

http://www.w3.org/2001/XMLSchema#string

Sophie Chheang

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical applications of intracranial perfusion MR imaging.

Perfusion imaging in the pediatric patient.

Dynamic susceptibility contrast MRI of gliomas.

Perfusion MR imaging: basic principles and clinical applications.

Update on brain tumor imaging: from anatomy to physiology.

Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors.

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.

Contrast agents and cerebral hemodynamics.

Prospective clinical trials of intracranial low-grade glioma in adults and children.

Limitations of stereotactic biopsy in the initial management of gliomas.

P304

490-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2472070898

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

247

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18349315

http://www.w3.org/2001/XMLSchema#string

P932

3774106

http://www.w3.org/2001/XMLSchema#string